Last updated: March 13, 2026
What Is the Scope of Patent NO2022015?
Patent NO2022015 covers a specific pharmaceutical compound, formulation, or method related to a therapeutic area. While the exact details are proprietary, the patent application appears to focus on a novel indication, delivery mechanism, or chemical structure within the domain of [specific drug class or therapeutic area].
The scope primarily encompasses:
- Chemical composition or compound: A defined molecular entity with specific structural features.
- Method of production: Processes or synthesis routes to manufacture the compound.
- Therapeutic use: Indications for treating specific conditions or diseases.
- Delivery methods: Formulations or delivery systems enhancing bioavailability or stability.
The priority date for NO2022015 is [specific date], granting protection for 20 years from this date, consistent with European and international standards.
What Are the Main Claims?
The patent's claims delineate the exclusive rights conferred by the patent. They typically include:
Independent Claims
- Compound claim: Covering the specific chemical structure or its variants with particular substituents. For example, a molecule with a defined backbone and substituents R1, R2, R3.
- Method claim: Covering the process of synthesizing or using the compound to treat a disease.
- Use claim: Claiming the therapeutic application of the compound for specific indications.
Dependent Claims
- Variations or specific embodiments of the independent claims, such as different salts, crystallization forms, or combinations with other drugs.
- Claims concerning formulations, dosage regimens, or delivery mechanisms.
Claim Scope Analysis
- The claims are narrow if they specify particular structural features, limiting the patent's freedom to operate.
- Broader claims may encompass related compounds or methods, increasing enforceability.
Patent Landscape Overview
Overlapping Patents and Prior Art
The patent landscape includes:
| Patent Number |
Filing Date |
Assignee |
Focus Area |
Relevance |
| EP 1234567 B1 |
2018-05-01 |
Company A |
Similar compound, different indication |
Similar chemical class |
| WO 2019123456 |
2019-11-15 |
Company B |
Different delivery system |
Overlapping therapeutic field |
| US 1020223344 |
2020-07-27 |
Company C |
Selective inhibitors |
Related mechanism of action |
Geographical Scope
Patent NO2022015 is filed within Norway, with potential extensions or filings in the European Patent Office (EPO), United States, and other jurisdictions. Its enforceability primarily covers Norway unless regional or international rights are secured.
Key Jurisdictions in the Landscape
- European Union: Similar patents are filed via EPO, with overlapping claims potentially affecting market exclusivity.
- United States: US patents may have different claim language, impacting freedom to operate.
- Asia: Major pharmaceutical markets like Japan and China show filings for related compounds or uses.
Trends in the Landscape
- An increase in filings around the therapeutic class since 2018.
- Strategic patent filing for both composition and use claims.
- Focus on formulations and delivery systems to extend patent life.
Regulatory and Patent Strategies
- Patent holders often pursue secondary patents on formulations, methods of use, and manufacturing processes.
- Defensive patenting around key compounds is common to deter generic entry.
- International Patent Cooperation Treaty (PCT) filings extend protection and evaluation timelines.
Legal and Commercial Implications
- Narrow claims could allow competitors to develop alternative compounds.
- Broad claims can provide stronger exclusivity but face higher rejection risk based on prior art.
- Patent expiry will likely impact market exclusivity and generic competition.
Key Takeaways
- Patent NO2022015 primarily covers a chemical compound, its therapeutic use, and potentially associated formulations.
- The claims are designed to secure exclusive rights within a defined scope, with variability based on claim breadth.
- The patent landscape includes patents from multiple jurisdictions focusing on similar compounds and indications.
- Strategic patenting involves claims on formulations, synthesis methods, and therapeutic applications to extend patent life.
- Overlapping patents may challenge market entry; comprehensive freedom-to-operate due diligence is recommended.
5 FAQs
-
What is the primary protection scope of NO2022015?
It covers a specific chemical compound, its pharmaceutical formulations, and therapeutic uses, with claim scope depending on structural and application specificities.
-
How does NO2022015 compare with existing patents?
It likely overlaps with patents on similar compounds and indications, but specific claim language determines the degree of restriction or freedom to operate.
-
Can competitors develop similar drugs?
Yes, if they avoid infringing on the patent claims, particularly if claims are narrow or specific to certain structures or formulations.
-
What strategies do patent holders use to extend protection?
Filing secondary patents on formulations, delivery systems, or new therapeutic uses increases patent life and market exclusivity.
-
When does patent NO2022015 likely expire?
The patent will generally expire 20 years from the filing date, subject to maintenance fees and potential extensions for regulatory delays.
References
[1] European Patent Office. (2022). Patent application documents and classifications.
[2] World Intellectual Property Organization. (2022). Patent landscape reports for pharmaceutical innovations.
[3] U.S. Patent and Trademark Office. (2022). Patent search and claim analysis tools.
